tiprankstipranks
Trending News
More News >
Predictive Oncology Inc (POAI)
NASDAQ:POAI
US Market

Predictive Oncology (POAI) Stock Forecast & Price Target

Compare
468 Followers
See the Price Targets and Ratings of:

POAI Financial Forecast

POAI Earnings Forecast

The previous quarter’s earnings for POAI were -$0.34.
The previous quarter’s earnings for POAI were -$0.34.

POAI Sales Forecast

The previous quarter’s earnings for POAI were $110.31K.
The previous quarter’s earnings for POAI were $110.31K.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on POAI
TipRanks AITipRanks
Not Ranked
TipRanks
$1
Sell
11.11%
Upside
Downgraded
06/12/25
The overall stock score is heavily influenced by severe financial challenges and the risk of Nasdaq delisting. The company's negative financial performance and valuation metrics are significant concerns. Technical analysis suggests bearish momentum, while the potential delisting exacerbates the risk profile.
H.C. Wainwright Analyst forecast on POAI
Swayampakula RamakanthH.C. Wainwright
H.C. Wainwright
Hold
Downgraded
11/15/24
H.C. Wainwright downgrades Predictive Oncology (POAI) to a Hold
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on POAI
TipRanks AITipRanks
Not Ranked
TipRanks
$1
Sell
11.11%
Upside
Downgraded
06/12/25
The overall stock score is heavily influenced by severe financial challenges and the risk of Nasdaq delisting. The company's negative financial performance and valuation metrics are significant concerns. Technical analysis suggests bearish momentum, while the potential delisting exacerbates the risk profile.
H.C. Wainwright Analyst forecast on POAI
Swayampakula RamakanthH.C. Wainwright
H.C. Wainwright
Hold
Downgraded
11/15/24
H.C. Wainwright downgrades Predictive Oncology (POAI) to a Hold
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

POAI Analyst Recommendation Trends

Rating
Jun 21
Nov 21
Nov 22
Aug 24
Nov 24
Strong Buy
0
0
1
2
2
Buy
2
3
2
1
0
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
3
3
3
3
In the current month, POAI has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. POAI average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

POAI Stock Forecast FAQ

What is POAI’s average 12-month price target, according to analysts?
Currently, no data Available
What is POAI’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for POAI, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is POAI a Buy, Sell or Hold?
      Predictive Oncology Inc has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Predictive Oncology Inc’s price target?
        Currently, no data Available
        What do analysts say about Predictive Oncology Inc?
        Predictive Oncology Inc’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of POAI?
          Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis